Clinical Trials Directory

Trials / Sponsors / Liquidia Technologies, Inc.

Liquidia Technologies, Inc.

Industry · 8 registered clinical trials — 1 currently recruiting.

StatusTrialPhaseStarted
Not Yet RecruitingA Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD
Pulmonary Hypertension Due to Lung Disease (Disorder)
Phase 32026-04-01
Active Not RecruitingAn Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprost
Pulmonary Hypertension, Interstitial Lung Disease
—2023-12-28
Active Not RecruitingA Phase 3 Study to Evaluate the Safety and Tolerability of L606 in Subjects With PAH or PH-ILD
Pulmonary Arterial Hypertension, Pulmonary Hypertension Due to Lung Diseases
Phase 32021-08-01
TerminatedHemodynamic Evaluation of Dose-response and Safety of Dry Powder Inhalation of Treprostinil
Pulmonary Arterial Hypertension
Phase 22019-11-11
Active Not RecruitingExtension Study for Participants in LIQ861 Trials to Evaluate the Long-term Safety of Dry Powder Inhalation of
Primary Pulmonary Hypertension
Phase 32019-07-18
CompletedInvestigation of the Safety and Pharmacology of Dry Powder Inhalation of Treprostinil
Primary Pulmonary Hypertension
Phase 32018-01-02
CompletedSingle Ascending Dose Study of Two Liquidia Bupivacaine Formulations
Acute Pain
Phase 12016-12-05
CompletedA Study Evaluating the Safety and Tolerability of a Seasonal Influenza Vaccine Containing LIQ001
Influenza
Phase 1 / Phase 22010-09-01